Data from a Phase II clinical trial of Xeloda and exaliplatin given before surgery to advanced gastric cancer patients with para-aortic lymph node metastasis.
A data frame with 48 observations on the following 2 variables.
survival time in weeks
1 for death, 0 for censored
The data were extracted from the Kaplan-Meier survival plot.
Wang Y, Yu Y-Y, Li W, Feng Y, Hou J, Ji Y, Sun Y-H, Shen K-T, Shen Z-B, Qin X-Y, and Liu T-S. (2014) A phase II trial of xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemotherapy and Pharmacology 73(6), 1155-1161.))
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.